Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares NTRK fusion-positive non-small-cell lung cancer, RET fusion-positive non-small-cell lung cancer, ROS1-positive non-small-cell lung cancer, Non-small cell lung cancer (KEGG map) and the tags subtype-page, lung.
Shares David Planchard, PD-L1-high non-small-cell lung cancer without a driver mutation, Pemetrexed, EGFR-mutated non-small-cell lung cancer and the tags subtype-page, lung.
Shares PD-L1-high non-small-cell lung cancer without a driver mutation, Pemetrexed, EGFR-mutated non-small-cell lung cancer, PD-L1 and the tags subtype-page, lung.
Shares PD-L1, Carboplatin, Immune checkpoint inhibitors and the tags subtype-page, lung.
Shares PD-L1, PD-1, Carboplatin, Immune checkpoint inhibitors and the tags subtype-page, lung.
Shares MET exon 14 and MET-amplified non-small-cell lung cancer, PD-L1-high non-small-cell lung cancer without a driver mutation, KRAS G12C-mutant non-small-cell lung cancer, Pemetrexed and the tags subtype-page, lung.
Shares Pemetrexed, Carboplatin, Pembrolizumab, Non-small-cell lung cancer and the tags subtype-page, lung.
Shares Pemetrexed, EGFR-mutated non-small-cell lung cancer, Non-small-cell lung cancer and the tags subtype-page, lung.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.